Asher Goldstein, MD
Pain Medicine · Hackensack, NJNPI 1790725661
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,914 of the $8,131 with a category attached, or 60.4%. 29 manufacturers reported payments, led by Relievant Medsystems, Inc. at 38.2% of the total. 2025 is the largest year on record at $3,232, 5.2 times the $625 reported in 2019.
Across 114 payments — averaging $71.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$3K
- Saluda Medical Americas, Inc.$2K
- Abbott$451
- Medtronic$284
- Curonix LLC$243
- SPR Therapeutics, Inc$228
- plus $1K from 23 others
What the payments were for
- Travel & lodging$3,17839%
- Food & beverage$4,91460%
- Education$380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 15 | $3,105 |
| Saluda Medical Americas, Inc. | 23 | $2,383 |
| Abbott | 18 | $451 |
| Medtronic(2 entities) | 4 | $284 |
| Curonix LLC | 3 | $243 |
| SPR Therapeutics, Inc | 6 | $228 |
| MML US, Inc. | 8 | $228 |
| Spinal Simplicity, LLC | 3 | $202 |
| Boston Scientific | 5 | $183 |
| Nalu Medical, Inc. | 2 | $177 |
| Foundation Fusion Solutions, LLC | 2 | $125 |
| Globus Medical | 1 | $104 |
| Bioventus LLC | 1 | $81 |
| GRT US Holding, Inc. | 1 | $42 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| Vertos Medical, Inc. | 3 | $33 |
| IBSA Pharma Inc. | 2 | $27 |
| Biodelivery Sciences International, Inc. | 2 | $27 |
| AstraZeneca | 2 | $25 |
| Collegium Pharmaceutical, Inc. | 2 | $23 |
| Biotronik NRO, Inc. | 1 | $18 |
| Protega Pharmaceutials Inc | 1 | $16 |
| Nevro Corp. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $13 |
| GSK | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $12 |
| Virtus Pharmaceuticals LLC | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$10,692
- Evoke$1,894
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$216
- HA MINUTEMAN G3-R$151
- Nalu Neurostimulation System$143
- ReActiv8$127
- O-ARM$123
- Neuromodulation Dspsbls and Accs$115
- Senza$104
- SPRINT PNS System$103
- MYSTIM$102
How this compares
$8,131 in reported general payments places this provider in the 85th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 22 | $15,213 |
| Buprenorphine | 73 | $13,250 |
| Xtampza ErOxycodone Myristate | 11 | $7,953 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 253 | $5,289 |
| Oxycodone Hcl | 191 | $3,859 |
| Gabapentin | 173 | $1,904 |
| Fentanyl | 33 | $1,800 |
| Naproxen | 77 | $1,433 |
| Celecoxib | 43 | $1,410 |
| Cyclobenzaprine Hcl | 59 | $1,106 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $763 |
| Hydromorphone Hcl | 36 | $735 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $694 |
| Duloxetine Hcl | 54 | $659 |
| Tramadol Hcl | 57 | $304 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $23 | $7,95311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 256 pain medicine providers in New Jersey.
Other pain medicine in Hackensack
- Samyadev DattaHackensack$9K
- Gary PanagiotakisHackensack$7K
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.